Personalis Profit Margin 2018-2023 | PSNL
Current and historical gross margin, operating margin and net profit margin for Personalis (PSNL) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Personalis net profit margin as of December 31, 2023 is -147.38%.
| Personalis Annual Profit Margins |
|---|
| Personalis Quarterly Profit Margins |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.064B | $0.073B |
| Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $14.440B | 5.21 |
| Dr Reddy's Laboratories (RDY) | India | $12.040B | 19.04 |
| Aspen Pharmacare (APNHY) | South Africa | $5.172B | 0.00 |
| BridgeBio Pharma (BBIO) | United States | $4.408B | 0.00 |
| Bausch Health Cos (BHC) | Canada | $3.088B | 2.41 |
| Amphastar Pharmaceuticals (AMPH) | United States | $1.963B | 13.44 |
| Supernus Pharmaceuticals (SUPN) | United States | $1.626B | 0.00 |
| Taysha Gene Therapies (TSHA) | United States | $0.460B | 0.00 |
| Generation Bio (GBIO) | United States | $0.187B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.072B | 0.00 |
| Acasti Pharma (ACST) | Canada | $0.027B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.026B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.004B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |